Receptors, Tumor Necrosis Factor, Type II

"Receptors, Tumor Necrosis Factor, Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.

Descriptor ID	D047889
MeSH Number(s)	D12.776.543.750.705.852.760.798
Concept/Terms	Receptors, Tumor Necrosis Factor, Type II Receptors, Tumor Necrosis Factor, Type II Receptors, Tumor Necrosis Factor, Member 1B TNF-R2 TNF-R75 TNF-RII TNFR p75 Tumor Necrosis Factor Receptor 75 Tumor Necrosis Factor Receptor 2 TNFR2 Tumor Necrosis Factor Receptor Type 2 Tumor Necrosis Factor Receptor Type II Antigens, CD120b CD120b Antigens TNFRSF1B Receptor Receptor, TNFRSF1B Tumor Necrosis Factor Receptor Superfamily, Member 1B CD 120b Antigen 120b Antigen, CD Antigen, CD 120b CD120b Antigen Antigen, CD120b TNFR p80 TNFR p80 TNF-sR75 TNF-sR75

Below are MeSH descriptors whose meaning is more general than "Receptors, Tumor Necrosis Factor, Type II".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Tumor Necrosis Factor [D12.776.543.750.705.852.760]
Receptors, Tumor Necrosis Factor, Type II [D12.776.543.750.705.852.760.798]

Below are MeSH descriptors whose meaning is related to "Receptors, Tumor Necrosis Factor, Type II".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Tumor Necrosis Factor, Type II".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in this website by year, and whether "Receptors, Tumor Necrosis Factor, Type II" was a major or minor topic of these publications.

Bar chart showing 10 publications over 7 distinct years, with a maximum of 3 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	2	3
2005	1	0	1
2008	1	0	1
2014	1	0	1
2016	1	0	1
2017	1	0	1
2019	1	1	2

Below are the most recent publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in Profiles.

Raphael I, Gomez-Rivera F, Raphael RA, Robinson RR, Nalawade S, Forsthuber TG. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019 12 19; 4(24).

View in: PubMed
Laczko R, Chang A, Watanabe L, Petelo M, Kahaleua K, Bingham JP, Csiszar K. Anti-inflammatory activities of Waltheria indica extracts by modulating expression of IL-1B, TNF-a, TNFRII and NF-?B in human macrophages. Inflammopharmacology. 2020 Apr; 28(2):525-540.

View in: PubMed
Parnell EA, Walch EM, Lo DD. Inducible Colonic M Cells Are Dependent on TNFR2 but Not Lt?r, Identifying Distinct Signalling Requirements for Constitutive Versus Inducible M Cells. J Crohns Colitis. 2017 Jun 01; 11(6):751-760.

View in: PubMed
Chang YW, Assari S, Prossin AR, Stertz L, McInnis MG, Evans SJ. Bipolar disorder moderates associations between linoleic acid and markers of inflammation. J Psychiatr Res. 2017 02; 85:29-36.

View in: PubMed
Sasi SP, Song J, Park D, Enderling H, McDonald JT, Gee H, Garrity B, Shtifman A, Yan X, Walsh K, Natarajan M, Kishore R, Goukassian DA. TNF-TNFR2/p75 signaling inhibits early and increases delayed nontargeted effects in bone marrow-derived endothelial progenitor cells. J Biol Chem. 2014 May 16; 289(20):14178-93.

View in: PubMed
Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J. 2008 May 19; 7:83.

View in: PubMed
Rojas-Cartagena C, Appleyard CB, Santiago OI, Flores I. Experimental intestinal endometriosis is characterized by increased levels of soluble TNFRSF1B and downregulation of Tnfrsf1a and Tnfrsf1b gene expression. Biol Reprod. 2005 Dec; 73(6):1211-8.

View in: PubMed
Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004 Dec 16; 351(25):2599-610.

View in: PubMed
Joshipura KJ, Wand HC, Merchant AT, Rimm EB. Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res. 2004 Feb; 83(2):151-5.

View in: PubMed
Ueda Y, Yang K, Foster SJ, Kondo M, Kelsoe G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med. 2004 Jan 05; 199(1):47-58.

View in: PubMed

People

Explore

Similar Concepts

Top Journals